BioVenic

What BioVenic does

BioVenic is a privately held biotechnology company specializing in multi-species animal research and development, operating globally as both a contract research organization (CRO) and a catalog supplier of animal-derived research reagents. The company serves research institutions, animal health companies, and related B2B customers across five primary verticals: companion animals (canine, feline, equine), livestock (beef/dairy cattle, sheep, goats, swine), poultry (chicken, turkey, goose, duck), aquaculture (farmed fish, shellfish, shrimp), and economic insects (silkworm, honeybee). BioVenic's product catalog spans research reagents including animal proteins, cells and cell lines, veterinary antibodies and antigens, species-specific immunoassay/ELISA kits, PCR/qPCR kits, and food/feed safety assay kits. Its CRO service portfolio covers animal breeding and genetics (genomic selection, CRISPR editing, genotyping, multi-omics), veterinary biological therapeutics development (therapeutic antibodies, cell-based therapies, vaccines, diagnostics, organoid solutions), preclinical in vivo studies, and animal nutrition and feed development.

The underlying technology platform integrates genomics, transcriptomics, proteomics, metabolomics, epigenomics, and microbiome analysis with cell biology capabilities including custom cell isolation, stable cell line generation, stem cell solutions, and organoid culture systems. Notable technical components include a Veterinary Organoid Culture System with animal-free recombinant proteins and organoid-on-chip workflows, a species-specific CAR technology platform for veterinary immune cell therapies, and multi-omics selection tools for animal breeding programs. Recent launches include the enhanced Veterinary Organoid Culture System (announced June 2026) and the Veterinary CAR Technology Platform (announced November 2025), signaling movement into higher-value therapeutic development and animal-free 3D culture technologies.

BioVenic employs a sales-led B2B go-to-market motion, using a website quote request system and direct enterprise sales engagement rather than self-service e-commerce checkout. Pricing is opaque and quote-based, consistent with custom R&D project work and B2B reagent sales. The company is incorporated in the United States as Biovenic, Inc., operates without disclosed external investors or parent company ownership, and derives revenue from two streams: fee-for-service CRO contracts and one-time product sales of research reagents. No revenue figures, funding rounds, or named enterprise customer logos are publicly disclosed.

Name

BioVenic

Legal name

Biovenic, Inc.

Website

https://biovenic.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

BioVenic is a privately held B2B biotechnology company providing multi-species animal research reagents and contract research services in genomics, cell biology, organoid culture, and veterinary biologics development for institutions and animal health companies across companion animals, livestock, poultry, aquaculture, and insects.

Ownership category

akta.pro rank

Product category

Veterinary Biotechnology R&D Services

NAICS

Veterinary Services (54194)

SIC

Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYAFAEANAK

Veterinary Pharmacy, Vaccine & Biologics Services

Agriculture & Food Production/Animal Production & Aquaculture/Animal Health & Veterinary Services

SECONDARYHLAMAKAM

Vaccine R&D, Clinical/Field Trials & Regulatory Affairs

Healthcare & Life Sciences/Veterinary & Animal Health/Animal Vaccines

SECONDARYHLAMANAI

Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing)

Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals

SECONDARYHLAMANAL

Clinical Research, Trials & Translational Services (Veterinary Regenerative)

Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals

SECONDARYHLAMAEAB

Livestock & Production Animal Therapeutics (Rx)

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

SECONDARYHLAMAIAH

Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)

Keywords

• Veterinary biotechnology services
• Animal genomics research
• Veterinary therapeutics development
• Animal breeding genetics
• Veterinary diagnostics development

Headquarters

HQ city

Hauppauge

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. R&D Services (CRO): Contract research organization providing fee-for-service R&D solutions including genomic analysis, cell culture development, vaccine development, therapeutic antibody development, and preclinical studies. Revenue generated through project-based service fees and long-term research contracts.
2. Animal R&D Reagents and Products: Sale of animal-derived products including proteins, cells, cell lines, veterinary antibodies, antigens, and immunoassay kits for various animal species.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

BioVenic operates as a contract research organization (CRO) and research reagent supplier for multi-species animal health and biotechnology R&D. The company delivers customized R&D services spanning animal breeding and genetics (genomic selection, CRISPR editing, multi-omics), veterinary biological therapeutics development (antibodies, proteins, peptides, cell therapies, vaccines), veterinary diagnostics, organoid culture systems, preclinical in vivo studies, and animal nutrition/feed development. It also sells animal-derived research reagents including proteins, cells, cell lines, antibodies, antigens, immunoassay kits, PCR/qPCR kits, and food/feed safety products for multiple animal species.

Product overview

BioVenic is a biotechnology company offering a dual portfolio of animal R&D reagents and CRO services for multi-species animal health research. The product line includes animal-derived research reagents (Animal Proteins, Animal Cells and Cell Lines), immunoassay products (Veterinary Antibodies, Antigens, and species-specific ELISA kits), molecular biology tools (PCR/qPCR Kits), and food/feed safety products. The services platform spans four major areas: Animal Breeding and Genetics (genomic selection, CRISPR genome editing, sequencing, and multi-omics); Veterinary Biological Therapeutics Development (therapeutic antibodies, cell-based therapies, vaccines, and organoid solutions); Veterinary Diagnostics Development (immunodiagnostics, molecular diagnostics, and specialty disease panels); and Animal Nutrition and Feed Development (metabolism analysis, feed additives, and safety testing). The company operates as a one-stop solution provider serving livestock, poultry, aquaculture, companion animals, and economic insects research markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Animal Breeding and Genetics Services Comprehensive CRO services including genomic selection, precision breeding, genome editing (CRISPR), genome sequencing, genotyping, and multi-omics solutions for animal breeding programs across multiple livestock and aquaculture species.
• Veterinary Biological Therapeutics Development End-to-end development services for veterinary biologics including therapeutic antibodies, therapeutic proteins, peptides, and cell-based therapies for multiple animal species.
• Veterinary Therapeutic Antibody Development Species-specific therapeutic antibody discovery, engineering, production, and evaluation services spanning early research through preclinical development for veterinary applications.
• Veterinary Vaccine Development Comprehensive vaccine development services covering live attenuated, inactivated, recombinant vectored, subunit, VLP, DNA, RNA, and phage-based platforms for multiple animal species.
• Veterinary Cell-based Therapy Development Development services for autologous, allogeneic, and xenogeneic cell therapies including MSC therapy, iPSC therapy, and immune cell solutions for veterinary applications.
• Veterinary Diagnostics Development Development services for immunodiagnostics, molecular diagnostics, urinalysis, and specialty diagnostics for infectious diseases, oncology, allergies, and metabolic disorders in animals.
• Veterinary Organoid Solution Organoid culture system development service combining animal-free recombinant proteins, 3D organoid modeling, and organoid-on-chip technologies for veterinary drug evaluation and disease modeling.
• Preclinical In Vivo Solution Preclinical research services including animal model development, histopathology, cell biology, behavioral analysis, imaging, and pharmacokinetics/pharmacodynamics studies.
• Animal Nutrition and Feed Development Comprehensive services including nutrition and metabolism analysis, omics solutions, feed additive development (probiotics, prebiotics, postbiotics, enzymes), mycotoxin solutions, and feed safety testing.
• Custom Animal Cell Solutions Custom services for animal cell isolation, culture development, stable cell line generation, cell-based assays, and stem cell solutions including MSC, iPSC, and embryonic stem cells.
• Veterinary Antibodies Catalog antibodies developed for veterinary applications, supporting diagnostics and research across multiple animal species.
• Veterinary Antigens Catalog antigens for veterinary diagnostic and research applications across various animal species.
• Animal-targeted Antibodies Catalog antibodies specifically targeting animal proteins for research and diagnostic purposes.
• Animal Immunoassay Kits Catalog ELISA kits for canine, feline, bovine, swine, equine, ovine, caprine, rodent, avian, rabbit, and aquaculture species for disease detection and research.
• PCR/qPCR Kits Catalog molecular biology kits for polymerase chain reaction and quantitative PCR applications in animal genetics and disease research.
• Animal Proteins Catalog animal-derived proteins used as research reagents for animal breeding, genetics, and veterinary biologicals development.
• Animal Cells and Cell Lines Catalog animal-derived cells and established cell lines used for veterinary research, drug screening, and therapeutic development.
• Food and Feed Safety Assay Kits Catalog assay kits for detecting contaminants, toxins, and safety parameters in animal feed and food products.
• Food and Feed Safety Antibodies Catalog antibodies for food and feed safety testing applications.
• Food and Feed Safety Antigens Catalog antigens for food and feed safety testing and analysis.
• Veterinary CAR Technology Platform Platform service for developing immune cell therapies for veterinary applications, focusing on species-specific CAR technology targeting conditions such as canine lymphoma and feline leukemia.

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• Bethyl Laboratories: Manufacturer and supplier of research antibodies with a strong catalog of animal-species-specific reagents (including veterinary applications). Direct peer in the catalog antibody/immunoassay reagent business serving veterinary and animal research customers.
• IDEXX BioAnalytics: Veterinary diagnostics laboratory and research services provider offering species-specific testing panels, immunoassays, and biorepository services. Directly comparable to BioVenic's diagnostics development and ELISA/antibody catalog across companion animal and livestock species.
• Life Diagnostics: Specialty manufacturer of ELISA kits and immunoassays targeting veterinary and animal research applications across multiple species. Directly comparable to BioVenic's species-specific ELISA catalog and food/feed safety assay kits.
• Syngene International: Contract research organization offering discovery, development, and manufacturing services across biologics, small molecules, and animal health. Directly comparable as a multi-modality CRO serving global clients with veterinary and animal health research offerings.
• Inotiv: Preclinical CRO providing animal model development, toxicology, and research services for biomedical and veterinary applications. Comparable to BioVenic's preclinical in vivo and animal model service lines.

Broad incumbents

• WuXi AppTec: Global CRO/CDMO with biologics, vaccine, cell therapy, and preclinical services that increasingly serve veterinary and animal health clients. Comparable to BioVenic's biologics development capabilities at enterprise scale.
• Charles River Laboratories: Global CRO with extensive preclinical and animal research services spanning discovery, safety assessment, and biologics manufacturing. Comparable as a competing veterinary/animal CRO at much larger scale, with overlapping capabilities in cell-based assays, vaccine development support, and species-specific in vivo studies.
• Elanco Animal Health: Major veterinary pharma company with portfolios in livestock and companion animal vaccines, therapeutics, and diagnostics. Adjacent incumbent competing for the same end-customers and CRO budgets as BioVenic across species.
• GenScript: Global biotech CRO offering gene synthesis, protein production, antibody discovery, and cell therapy services with animal and veterinary applications. Overlaps with BioVenic's therapeutic antibody, recombinant protein, and CRISPR services at greater scale and broader modality coverage.
• Zoetis: Largest pure-play animal health company, with deep capabilities in veterinary vaccines, diagnostics, biologics, and genetic testing. Comparable to BioVenic's veterinary therapeutics and diagnostics development as a dominant incumbent with vastly greater resources.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/BioVenic

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioVenic